Skip to main content
SpringerLink
Log in

Imaging of tumour hypoxia using PET and 18F-labelled tracers: biology meets technology

  • Editorial commentary
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

The Original Article was published on 20 April 2007

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Horsman MR, Overgaard J. The oxygen effect and tumour microenvironment. In: Steel GG, editor. Basic clinical radiobiology. London: Arnold; 2002; p. 158–68.

    Google Scholar 

  2. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996;379:88–91.

    Article  PubMed  CAS  Google Scholar 

  3. McCalla DR, Reuvers A, Kaiser C. Mode of action of nitrofurazone. J Bacteriol 1970;104:1126–34.

    PubMed  CAS  Google Scholar 

  4. Rischin D, Hicks RJ, Fisher R, Binns D, Corry J, Porceddu S, et al. Prognostic significance of 18F-misonidazole PET-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group study 98.02. J Clin Oncol 2006;24:2098–104.

    Article  PubMed  Google Scholar 

  5. Thorwarth D, Eschmann SM, Paulsen F, Alber M. Hypoxia dose painting by numbers: a planning study. Int J Radiat Oncol Biol Phys 2007;68:291–300.

    PubMed  Google Scholar 

  6. Chapman JD. Hypoxic sensitizers—implications for radiation therapy. N Engl J Med 1979;301:1429–32.

    Article  PubMed  CAS  Google Scholar 

  7. Bentzen SM. Theragnostic imaging for radiation oncology: dose-painting by numbers. Lancet Oncol 2005;6:112–7.

    Article  PubMed  Google Scholar 

  8. Rasey JS, Koh WJ, Evans ML, Peterson LM, Lewellen TK, Graham MM, et al. Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients. Int J Radiat Oncol Biol Phys 1996;36:417–28.

    Article  PubMed  CAS  Google Scholar 

  9. Kubota K, Tada M, Yamada S, Hori K, Saito S, Iwata R, et al. Comparison of the distribution of fluorine-18 fluoromisonidazole, deoxyglucose and methionine in tumour tissue. Eur J Nucl Med 1999;26:750–7.

    Article  PubMed  CAS  Google Scholar 

  10. Yang DJ, Wallace S, Cherif A, Li C, Gretzer MB, Kim EE, et al. Development of F-18-labeled fluoroerythronitroimidazole as a PET agent for imaging tumor hypoxia. Radiology 1995;194:795–800.

    PubMed  CAS  Google Scholar 

  11. Grönroos T, Eskola O, Lehtiö K, Minn H, Marjamäki P, Bergman J, et al. Pharmacokinetics of [18F]fluoroerythronitroimidazole: a potential hypoxia marker for PET. J Nucl Med 2001;42:1397–404.

    PubMed  Google Scholar 

  12. Rasey JS, Hofstrand PD, Chin LK, Tewson TJ. Characterization of [18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia. J Nucl Med 1999;40:1072–9.

    PubMed  CAS  Google Scholar 

  13. Sorger D, Patt M, Kumar P, Wiebe LI, Barthel H, Seese A, et al. [18F]fluoroazomycinarabinofuranoside (18FAZA) and [18F]fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors. Nucl Med Biol 2003;30:317–26.

    Article  PubMed  CAS  Google Scholar 

  14. Piert M, Machulla HJ, Picchio M, Reischl G, Ziegler S, Kumar P, et al. Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside. J Nucl Med 2005;46:106–13.

    PubMed  Google Scholar 

  15. Mahy P, De Bast M, Gillart J, Labar D, Gregoire V. Detection of tumour hypoxia: comparison between EF5 adducts and [18F]EF3 uptake on an individual mouse tumour basis. Eur J Nucl Med Mol Imaging 2006;33:553–6.

    Article  PubMed  CAS  Google Scholar 

  16. Dolbier WR, Li AR, Koch CJ, Shiue CY, Kachur AV. [18F]-EF5, a marker for PET detection of hypoxia: synthesis of precursor and a new fluorination procedure. Appl Radiat Isot 2001;54:73–80.

    Article  PubMed  CAS  Google Scholar 

  17. Ziemer LS, Evans SM, Kachur AV, Shuman AL, Cardi CA, Jenkins WT, et al. Noninvasive imaging of tumor hypoxia in rats using the 2-nitroimidazole 18F-EF5. Eur J Nucl Med Mol Imaging 2003;30:259–66.

    Article  PubMed  CAS  Google Scholar 

  18. Lehtiö K, Oikonen V, Grönroos T, Eskola O, Kalliokoski K, Bergman J, et al. Imaging of blood flow and hypoxia in head and neck cancer: initial evaluation with [15O]H2O and [18F]fluoroerythronitroimidazole PET. J Nucl Med 2001;42:1643–52.

    PubMed  Google Scholar 

  19. Lehtiö K, Eskola O, Viljanen T, Oikonen V, Grönroos T, Sillanmäki L, et al. Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;59:971–82.

    Article  PubMed  Google Scholar 

  20. Grönroos T, Bentzen L, Marjamäki P, Murata R, Horsman MR, Keiding S, et al. Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma. Eur J Nucl Med Mol Imaging 2004;31:513–20.

    Article  PubMed  CAS  Google Scholar 

  21. Souvatzoglou M, Grosu AL, Krause BJ, Beck R, Reischl G, Picchio M, et al. Tumour hypoxia imaging with [18F]FAZA PET in head and neck cancer patients: a pilot study. Eur J Nucl Med Mol Imaging 2007; DOI 10.1007/s00259-007-0424-3.

  22. Stypinski D, McQuarrie SA, Wiebe LI, Tam YK, Mercer JR, McEwan AJ. Dosimetry estimations for 123I-IAZA in healthy volunteers. J Nucl Med 2001;42:1418–23.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Turku PET Centre and Medicity Research Laboratory, University of Turku, Tykistökatu 6 A, 20520, Turku, Finland

    Tove Grönroos & Heikki Minn

  2. Department of Oncology and Radiotherapy, Turku University Hospital, Turku, Finland

    Heikki Minn

Authors
  1. Tove Grönroos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Heikki Minn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tove Grönroos.

Additional information

This editorial commentary refers to the article http://dx.doi.org/10.1007/s00259-007-424-3.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grönroos, T., Minn, H. Imaging of tumour hypoxia using PET and 18F-labelled tracers: biology meets technology. Eur J Nucl Med Mol Imaging 34, 1563–1565 (2007). https://doi.org/10.1007/s00259-007-0487-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-007-0487-1

Search

Navigation